4.7 Article

Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: A randomized controlled trial

期刊

PSYCHIATRY RESEARCH
卷 319, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.psychres.2022.114975

关键词

Depressive disorder; Treatment -resistant; Healthy lifestyle; Mindfulness

向作者/读者索取更多资源

The study aimed to compare the effectiveness of a lifestyle modification program (LMP) with mindfulness-based cognitive therapy (MBCT) and a placebo-control in Spanish patients with treatment-resistant depression (TRD). The results showed that compared to the placebo group, the LMP and MBCT groups had better quality of life, the LMP group had better adherence to the Mediterranean diet, and reduced use of antidepressants. However, there were no significant differences in depression symptoms scores among the three groups.
Background: The high prevalence of depression is partly attributable to the poor response of patients to first-line antidepressants. Multimodal programs that promote a healthy lifestyle are successful in treating depression when used as a complementary therapy, but their medium-and long-term benefits have not been demonstrated for patients with treatment-resistant depression (TRD). The main aim of this study was to compare the effectiveness of a lifestyle modification program (LMP) with mindfulness-based cognitive therapy (MBCT) and a placebo -control (written suggestions for lifestyle changes) in Spanish patients with TRD.Methods: This controlled clinical trial randomized 94 patients with TRD into 3 arms. The primary outcome was the Beck Depression Inventory-II (BDI-II) score at baseline, 2, 6 and 12 months. The secondary outcomes were changes in scores that evaluated quality-of-life, adherence to the Mediterranean diet, physical activity, and social support.Results: Relative to the placebo group, the LMP and MBCT groups had significantly better quality of life (p = 0.017; p = 0.027), and the LMP group had significantly better adherence to the Mediterranean diet (p<0.001) and reduced use of antidepressants (p = 0.036). However, the three groups showed no significant differences in BDI-II score.Limitations: Only about half of the planned 180 patients were recruited, in part due to the COVID-19 pandemic.Conclusions: There was no evidence that the LMP treatment significantly reduced symptoms of depression relative to the other groups during the COVID-19 lockdown.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据